Molecular Imaging: Page 33

Hybrid imaging gives fresh hope to squamous cell carcinoma patients

By Will Morton

German researchers have found FDG-PET/CT was superior to MRI and CT alone for detecting metastases in patients with squamous cell carcinoma of the oral cavity. The early dissection of lymph node metastases may increase survival in these patients, they say.

April 29, 2021

Mediso completes acquisition of MRI spectrometer

By AuntMinnieEurope.com staff writers

Multimodality imaging technology provider Mediso Medical Imaging Systems has purchased the intellectual property of Cameleon4, an MRI spectrometer developed by longtime partner and French spectrometer firm RS2D.

April 25, 2021

German team finds cognitive recovery can be slow in COVID-19

By Will Morton

Hybrid imaging researchers from the University of Freiburg, Germany, have found that significant cognitive impairment persists in some chronic COVID-19 patients more than six months after the onset of the disease.

April 25, 2021

Hybrid imaging can illuminate sports-related brain injuries

By Will Morton

Swedish researchers have used PET/MRI and novel radiotracers to show long-term neurodegeneration in young athletes who have experienced sports-related concussion and traumatic brain injuries.

April 20, 2021

Martí-Bonmatí urges return to face-to-face radiology training

By Philip Ward

Around 90% of radiology training in Valencia, Spain, is now being done face-to-face rather than online, according to Dr. Luis Martí-Bonmatí, PhD, the winner of the 2021 EuroMinnies award for Most Effective Radiology Educator. Martí-Bonmatí discusses his team's approach to training, and also shares his thoughts on books, music, and wine.

April 12, 2021

Hybrid imaging proves value in staging of breast cancer

By Will Morton

PET/CT is very useful in detecting axillary metastases in breast cancer patients and provides important information about the extent of axillary and extra-axillary lymph node involvement, according to researchers from Tel Aviv University.

April 8, 2021

Fusion buys radiopharmaceutical from Ipsen

By AuntMinnieEurope.com staff writers

Fusion Pharmaceuticals has acquired the intellectual property and assets related to French firm Ipsen's IPN-1087 radiopharmaceutical.

April 1, 2021

German study highlights promise of radiotracer for prostate imaging

By Will Morton

Investigators from the Technical University of Munich have found that an experimental radiotracer is effective when used with PET/CT for detecting biochemically recurrent prostate cancer and may change patient management.

April 1, 2021

10 years on, PET/MRI begins to deliver in clinical arena

By Will Morton

A wide-ranging and timely special focus session held at ECR 2021 looked at the status of PET/MRI and the progress made over the past decade. Where are we now with "the prince that was promised"?

March 17, 2021

AI reduces FDG dose on PET imaging

By Kate Madden Yee

A European team of researchers has found that an artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquired at two-thirds of the standard radiopharmaceutical dose and produce diagnostically effective images, according to a study published on 9 March in EJNMMI Physics.

March 11, 2021

Tributes flow in for MRI and PET pioneer John Mallard

By AuntMinnieEurope.com staff writers

Medical physicist John Mallard, PhD, a pioneering researcher in MRI and early advocate of PET, has died at the age of 94, according to the University of Aberdeen in Scotland.

March 8, 2021

Whole-body MRI helps cancer patients where FDG-PET fails

By Wayne Forrest

FDG-PET/CT is the modality of choice for staging and assessing cancer patients, but whole-body MRI can make a valuable contribution to detection and diagnoses where the hybrid modality underperforms, ECR 2021 registrants learned at a special session on Sunday evening.

March 7, 2021

Previous Page

Page 33 of 120

Next Page